Characterization of a KPC-84 harboring Klebsiella pneumoniae ST11 clinical isolate with ceftazidime-avibactam resistance

被引：0
|
作者：
Gong, Yanqiao [1 ,2 ]
Feng, Yu [1 ,3 ]
Zong, Zhiyong [1 ,3 ,4 ]
Lv, Xiaoju [1 ,4 ]
机构：
[1] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China
[2] Hubei Minzu Univ, Minda Hosp, Dept Infect Control, Enshi, Peoples R China
[3] Sichuan Univ, West China Hosp, Ctr Pathogen Res, Chengdu, Peoples R China
[4] Div Infect Dis, State Key Lab Biotherapy, Chengdu, Peoples R China
来源：
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2024年 / 43卷 / 10期
基金：
中国国家自然科学基金;
关键词：
KPC; Ceftazidime-avibactam; Klebsiella pneumoniae;
D O I：
10.1007/s10096-024-04910-y
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
A novel KPC variant, KPC-84, identified in a Klebsiella pneumoniae isolate from China, exhibits a threonine (T) to proline (P) amino acid substitution at Ambler position 243(T243P), altering from the KPC-2 sequence. Cloning and expression of bla(KPC-84) in Escherichia coli, with subsequent MIC assessments, revealed increased resistance to ceftazidime-avibactam and significantly reduced carbapenemase activity compared to KPC-2. Kinetic measurements showed that KPC-84 exhibited sligthly higher hydrolysis of ceftazidime and reduced affinity for avibactam compared to KPC-2. This study emphasizes the emerging diversity of KPC variants with ceftazidime-avibactam resistance, underscoring the complexity of addressing carbapenem-resistant Klebsiella pneumoniae infections.
引用
收藏
页码：2029 / 2035
页数：7
相关论文
共 50 条
  • [21] Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of Klebsiella pneumoniae ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol
    Giufre, Maria
    Errico, Giulia
    Del Grosso, Maria
    Pagnotta, Michela
    Palazzotti, Bernardetta
    Ballardini, Milva
    Pantosti, Annalisa
    Meledandri, Marcello
    Monaco, Monica
    ANTIBIOTICS-BASEL, 2024, 13 (06):
  • [22] Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3
    Humphries, Romney M.
    Hemarajata, Peera
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
  • [23] Overexpression of KPC contributes to ceftazidime-avibactam heteroresistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae
    Li, Yitan
    Chen, Xiandi
    Guo, Yingyi
    Lin, Yingzhuo
    Wang, Xiaohu
    He, Guohua
    Wang, Mingzhen
    Xu, Jianbo
    Song, Mingdong
    Tan, Xixi
    Zhuo, Chao
    Lin, Zhiwei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [24] Characteristic of KPC-12, a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in the Carbapenem-Resistant Klebsiella pneumoniae ST11-KL47 Clone Background
    Han, Weihua
    Zhou, Peiyao
    Chen, Chun
    Wu, Chunyang
    Shen, Li
    Wan, Cailing
    Xiao, Yanghua
    Zhang, Jiao
    Wang, Bingjie
    Shi, Junhong
    Yuan, Xinru
    Gao, Haojin
    Wang, Hongxiu
    Zhou, Ying
    Yu, Fangyou
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 2541 - 2554
  • [25] Emergence and Recovery of Ceftazidime-avibactam Resistance in blaKPC-33-Harboring Klebsiella pneumoniae Sequence Type 11 Isolates in China
    Shi, Qingyu
    Yin, Dandan
    Han, Renru
    Guo, Yan
    Zheng, Yonggui
    Wu, Shi
    Yang, Yang
    Li, Shirong
    Zhang, Rong
    Hu, Fupin
    CLINICAL INFECTIOUS DISEASES, 2020, 71 : S436 - S439
  • [26] Ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in KPC-producing Klebsiella pneumoniae infections: A case series
    van Asten, S. A., V
    Boattini, M.
    Kraakman, M. E. M.
    Bianco, G.
    Iannaccone, M.
    Costa, C.
    Cavallo, R.
    Bernards, A. T.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (05) : 778 - 780
  • [27] Minimum inhibitory concentrations of aztreonam-avibactam, ceftazidime-avibactam and meropenem in clinical isolates of Klebsiella pneumoniae harboring carbapenemase genes
    Ageevets, Vladimir
    Sulian, Ofelia
    Avdeeva, Alisa
    Chulkova, Polina
    Ageevets, Irina
    Gostev, Vladimir
    Alieva, Kamilla
    Golikova, Maria
    Sidorenko, Sergey
    JOURNAL OF ANTIBIOTICS, 2024, 77 (10): : 706 - 710
  • [28] Conversion of bla KPC-2 to bla KPC-33 leads to worldwide emergence of ceftazidime-avibactam resistance in Klebsiella pneumoniae
    Lai, Yi-Chyi
    Lin, Luo-Wei
    Cheng, Yi-Chen
    Lee, Yu-Lin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (05)
  • [29] Diversity of Ceftazidime-Avibactam Resistance Mechanism in KPC2-Producing Klebsiella pneumoniae Under Antibiotic Selection Pressure
    Jiang, Min
    Sun, Bin
    Huang, Yong
    Liu, Chengyang
    Wang, Yan
    Ren, Yanli
    Zhang, Yuhong
    Wang, Yunying
    Mu, Di
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 4627 - 4636
  • [30] Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae
    Davido, Benjamin
    Cremieux, Anne-Claude
    Vaugier, Isabelle
    Gatin, Laure
    Noussair, Latifa
    Massias, Laurent
    Laurent, Frederic
    Saleh-Mghir, Azzam
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 61 (01)
12345